AI assistant
PCI Biotech Holding Director's Dealing 2019
3709_rns_2019-10-18_ed7a11c9-3db6-46e9-b08c-e028ace4b464.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
Stocken Invest AS, a wholly owned company by Lars Viksmoen, has on 18 October 2019 transferred 12,966 shares in PCI Biotech Holding ASA (“PCI Biotech”) to Lars Viksmoen, board member of PCI Biotech, at an average price of NOK 26.80 per share.
After the transaction, Lars Viksmoen holds 12,966 shares in PCI Biotech and Stocken Invest AS holds 0 shares in PCI Biotech.
This information is subject to the disclosure requirements pursuant to section 4-2 of the Norwegian Securities Trading Act.